The Saga of Cytomel (T3) for Treating Hypothyroidism Continues.
- In the US and UK T4 is the treatment of choice for hypothyroidism.
- UK Nurse suffered a severe reaction after taking thyroxine, T4, for her underactive thyroid and denied T3 for hypothyroidism despite taking it previously.
- She experienced extreme fatigue, hair loss and painful joints.
- She was prescribed Liothyronine, T3 and her symptoms disappeared.
- The symptoms are not usually associated with taking T4.
- National health put T3 on the black list and only endocrinologists can prescribe it.
- Under endocrinologist care a trial of T4 must be done to prove T4 really caused the her symptoms before T3 can be used in the UK.
- Following the publication of national guidelines from NHS England, there has been a review of the status of Liothyronine.
- Within the guidelines it’s deemed Liothyronine is of clinical value to a small group of patients and prescribing is limited to consultant endocrine physicians.
- Based on this primary care should no longer prescribe Liothyronine.
- Bravo NHS for a change.
- T3 is a dangerous form of thyroid hormone therapy and it’s use must be curtailed.
- T3 is a fast acting hormone with acute effects on the heart and it is correctly limited to rare use by endocrinologists only.
- The USA is behind the UK as any physician can write for T3 and this is dangerous and a thyroid consultation should be obtained it see if a switch to T3 is indicated.
- Consultation and a T3 trial test can be done at my office.